Cedazuridine is a cytidine deaminase inhibitor used as a pharmaceutical raw material. It is combined with decitabine to prevent its degradation, thereby enabling oral administration for epigenetic therapy.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1141397-80-9
JNJ-40346527
pharmaceutical raw material
Anthralin
pharmaceutical raw material
Capivasertib
pharmaceutical raw material
Ethyl (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate
pharmaceutical raw material
Tetrahydrouridine
pharmaceutical raw material
(4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one
VUDZSIYXZUYWSC-DBRKOABJSA-N
C1CN(C(=O)N[C@@H]1O)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F